Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium

Authors: Kathryn J. Fowler, Sudhakar K. Venkatesh, Nancy A. Obuchowski, Michael S. Middleton, Jun Chen, Kay Pepin, Jessica Magnuson, Kathy J Brown, Danielle Batakis, Walter C. Henderson, Sudha S. Shankar, Tania N. Kamphaus, A Pasek, Roberto A. Calle, Arun J. Sanyal, Rohit Loomba, Richard L. Ehman, Anthony E. Samir, Claude B. Sirlin, Sarah P. Sherlock - Radiology 2023 cited by 46

There is a need for reliable noninvasive methods for diagnosing and monitoring nonalcoholic fatty liver disease (NAFLD). Thus, the multidisciplinary Non-invasive Biomarkers of Metabolic Liver disease (NIMBLE) consortium was formed to identify and advance the regulatory qualification of NAFLD imaging biomarkers.